Table 1. Clinical and demographic characteristics in depressive patients and healthy controls.
Variables | Depressive Patients (n = 90) | Healthy Controls (n = 90) | F or χ2 | P-value |
---|---|---|---|---|
Gender (male/female) | 30/60 | 30/60 | 0.00 | 1.00 |
Age (years) | 34.98 ± 10.78 | 34.98 ± 10.70 | 0.00 | 1.00 |
Education (years) | 10.12 ± 3.34 | 9.74 ± 3.55 | 0.57 | 0.45 |
BMI (kg/m2) | 21.62 ± 3.16 | 24.13 ± 3.70 | 23.72 | <0.001 |
Smoking (smoker/nonsmoker) | 8/82 | 26/64 | 11.75 | <0.001 |
Suicide (attempter/no-attempter) | 56/34 | 0/90 | 81.29 | <0.001 |
Age of Illness Onset (years) | 31.30 ± 10.23 | |||
Age of First Hospitalization (years) | 33.67 ± 10.54 | |||
Duration of Illness (months) | 50.70 ± 90.31 | |||
Number of Hospitalizations | 0.96 ± 0.92 | |||
Types of Antidepressants | ||||
SNRI | 20 (22.22%) | |||
SSRI | 53 (58.89%) | |||
Never Taking Antidepressants | 17 (18.89%) | |||
SDS Standard Score | 61.77 ± 12.73 | |||
SAS Standard Score | 52.0 ± 12.14 | |||
Apolipoprotein B (g/L) | 0.86 ± 0.21 |
Mean ± SD (standard deviation); BMI = body mass index; SNRI = serotonergic and noradrenergic reuptake inhibitor; SSRI = selective serotonergic reuptake inhibitor; SDS: self-rating depression scale; SAS: self-rating anxiety scale.